Market Tracker

06/30 4:07am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

9.37
Delayed Data
As of Jun 29
 -0.46 / -4.68%
Today’s Change
8.84
Today|||52-Week Range
18.48
-33.78%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close9.83
Today’s open9.62
Day’s range-- - --
Volume1,908,774
Average volume (3 months)1,671,397
Market cap$1.0B
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+23.86%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book12.40

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc-0.28-1.90%
DBVTDBV Technologies SA-0.23-0.78%
LXRXLexicon Pharmaceutic...-0.26-3.19%
SGMOSangamo BioSciences ...-0.50-4.61%
Data as of 06/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
James F. Oliviero
Corporate headquarters
New York, New York

Forecasts